News and Insights

What's New

Prophylactic Mastectomy for Patients With High-Risk Gene Mutations

Prophylactic Mastectomy for Patients With High-Risk Gene Mutations

Dr. Andrew Hertler discussed the importance of prophylactic mastectomy for individuals carrying BRCA1, BRCA2 and other deleterious mutations.

Pancreatic Cancer Screening, the New Guidelines, and Barriers to Care

Pancreatic Cancer Screening, the New Guidelines, and Barriers to Care

Our CMO speaks with Urban Health Today about who should get screened, the role of primary care physicians in identifying at-risk individuals, and more.

Read External Article

Medicare Drug Price Negotiations and Anticipated Ripple Effects

Medicare Drug Price Negotiations and Anticipated Ripple Effects

Our vice president of pharmacy explores the hard-to-predict impacts of drug price negotiations on consumers, plans and pharmaceutical companies.

Read External Article

Genetic Testing in Cancer Care

Genetic testing in cancer care: Considerations for a condition-based approach

Two Evolent experts discuss the benefits of genetic testing in oncology in American Journal of Managed Care.

Read External Article

Evolent facilitates response to cancer drug shortages

Evolent facilitates response to cancer drug shortages

Evolent takes a multifaceted approach to help providers navigate shortages of cisplatin, carboplatin and other anti-cancer drugs.

Reducing Cancer Therapy’s Toll on the Heart

Reducing Cancer Therapy’s Toll on the Heart

Evolent is leveraging our expertise in two key specialties to reduce cardiovascular damage related to cancer drugs.

A 'Pink Tax' in Oncology

A 'Pink Tax' in Oncology?

Evolent addresses a startling difference in what men and women pay for the same drug.

When Less is More in Radiation Oncology

When Less is More in Radiation Oncology

An Evolent program reduces unnecessary radiation treatments for breast cancer without compromising efficacy.

How to Talk to Family Members About Hospice and End-of-Life Care

How to Talk to Family Members About Hospice and End-of-Life Care

Evolent's Connie Ducaine writes in MarketWatch that patients need to be proactive to ensure their preferences for end of life are respected.

Read External Article

Clinical Expertise When It Matters Most

Clinical Expertise When It Matters Most

Our evidence-driven, patient-first model helps produce more informed decisions.

Connecting Our Businesses. Connecting Care.

Connecting Our Businesses. Connecting Care.

Our solutions are coming together under one brand to improve outcomes for people with complex health conditions.

Evolent Announces Focus on Specialty Care With Rebrand, Unification of Solutions

Evolent Announces Focus on Specialty Care With Rebrand, Unification of Solutions

Company's solutions are coming together to improve outcomes for people living with complex health conditions.

Read Press Release

The Make-or-Break Moment for Payers in Specialty Care

The Make-or-Break Moment for Payers in Specialty Care

Our chief strategy officer speaks with Becker's about the largely untapped potential of value-based specialty care.

Bending the Oncology Cost Curve in 2023 and Beyond

Bending the Oncology Cost Curve in 2023 and Beyond

Our chief medical officer shares three trends likely to impact oncology drug spend in the near future.